Brokerages have given Selecta Biosciences, Inc. (NASDAQ:SELB) a consensus rating of “Buy.”
According to Bloomberg.com, the seven rating agencies currently monitoring the stock have given the stock of Selecta Biosciences, INC (NASDAQ: ...
Tag: SELB, Analyst Rating
Selecta Biosciences (SELB) will report third-quarter earnings on Thursday.
On Thursday, March 2, before the opening of the market, Selecta Biosciences, INC (NASDAQ: SELB) will release its quarterly earnings ...